NorthWest Biotherapeutics Inc (NWBO)

[learningcurve2020]

AI, There’s no assurance that the PIP is still green lighted since MHRA is now reaching out for opinions on EC PLD standards. It’d also explain why no pediatric L trial has even begun yet.

>>That’s just false. The pediatric plan explicitly adopted the adult trial design, including its control methodology and endpoints. Adjustments in secondary endpoints do not change the fact that the survival analysis structure, the backbone of both trials, is shared.